These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16051835)

  • 21. A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin.
    Viejo-Borbolla A; Kati E; Sheldon JA; Nathan K; Mattsson K; Szekely L; Schulz TF
    J Virol; 2003 Jun; 77(12):7093-100. PubMed ID: 12768028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen: Replicating and Shielding Viral DNA during Viral Persistence.
    Weidner-Glunde M; Mariggiò G; Schulz TF
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboxyl-terminal amino acids 1052 to 1082 of the latency-associated nuclear antigen (LANA) interact with RBP-Jκ and are responsible for LANA-mediated RTA repression.
    Jin Y; He Z; Liang D; Zhang Q; Zhang H; Deng Q; Robertson ES; Lan K
    J Virol; 2012 May; 86(9):4956-69. PubMed ID: 22379075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains.
    Matsumura S; Persson LM; Wong L; Wilson AC
    J Virol; 2010 Mar; 84(5):2318-30. PubMed ID: 20032179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest.
    Ottinger M; Christalla T; Nathan K; Brinkmann MM; Viejo-Borbolla A; Schulz TF
    J Virol; 2006 Nov; 80(21):10772-86. PubMed ID: 16928766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA.
    Canham M; Talbot SJ
    J Gen Virol; 2004 Jun; 85(Pt 6):1363-1369. PubMed ID: 15166417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.
    Togi S; Nakasuji M; Muromoto R; Ikeda O; Okabe K; Kitai Y; Kon S; Oritani K; Matsuda T
    Biochem Biophys Res Commun; 2015 Jul; 463(3):395-400. PubMed ID: 26032496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.
    Krithivas A; Fujimuro M; Weidner M; Young DB; Hayward SD
    J Virol; 2002 Nov; 76(22):11596-604. PubMed ID: 12388720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
    Si H; Robertson ES
    J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
    Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
    J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
    Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
    FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
    Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
    Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA.
    Barbera AJ; Chodaparambil JV; Kelley-Clarke B; Joukov V; Walter JC; Luger K; Kaye KM
    Science; 2006 Feb; 311(5762):856-61. PubMed ID: 16469929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
    Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
    Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    Lan K; Kuppers DA; Robertson ES
    J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.
    Beauchemin C; Moerke NJ; Faloon P; Kaye KM
    J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
    Cotter MA; Subramanian C; Robertson ES
    Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus through interaction with Daxx.
    Murakami Y; Yamagoe S; Noguchi K; Takebe Y; Takahashi N; Uehara Y; Fukazawa H
    J Biol Chem; 2006 Sep; 281(38):28113-21. PubMed ID: 16861237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.